- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Squamous Cell Carcinoma of the Esophagus
Total 4344 results
-
Centre Antoine LacassagneCompletedSquamous Cell Cutaneous Carcinoma of the SkinFrance
-
Dana-Farber Cancer InstituteWithdrawnSquamous Cell Carcinoma of the OropharynxUnited States
-
EMD SeronoCompletedSquamous Cell Carcinoma of the Head and Neck CancerCzech Republic, France, United Kingdom, Belgium, Hungary, United States, Poland, Slovakia
-
National Baromedical ServicesMayo Clinic; Dartmouth-Hitchcock Medical Center; Eastern Virginia Medical School and other collaboratorsCompletedCarcinoma, Squamous Cell | Cancer of the Head and NeckUnited States
-
Roswell Park Cancer InstituteCompletedStage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 | Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8United States
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Mayo ClinicRecruitingHead and Neck Carcinoma | Metastatic Malignant Neoplasm in the Lymph Nodes | Nasal Cavity Carcinoma | Oral Cavity Carcinoma | Paranasal Sinus Carcinoma | Salivary Gland Carcinoma | Cutaneous Squamous Cell Carcinoma of the Head and Neck | Hypopharyngeal Carcinoma | Laryngeal Carcinoma | Oropharyngeal Carcinoma and other conditionsUnited States
-
Glenn J. HannaSecura Bio, Inc.Active, not recruitingMetastatic Head and Neck Cancer | Advanced Head and Neck Squamous Cell Carcinoma | Recurrent Squamous Cell Carcinoma of the Head and Neck | Squamous Cell Carcinoma of the Head and Neck (SCCHN) | Advanced Head and Neck CancerUnited States
-
University Health Network, TorontoAstraZeneca; Mirati Therapeutics Inc.WithdrawnSquamous Cell Carcinoma, Head And Neck | Squamous Cell Carcinoma Mouth | Resectable Squamous Cell Carcinoma of Oral CavityCanada
-
ISA PharmaceuticalsRegeneron PharmaceuticalsActive, not recruitingSquamous Cell Carcinoma of the Oropharynx | HPV16 PositiveNetherlands, United States, United Kingdom, France, Belgium, Czechia, Spain, Italy, Germany, Brazil, Hungary, Mexico, Poland
-
Boston Scientific CorporationTerminatedEsophageal Cancer | Squamous Cell Carcinoma | Adenocarcinoma of the EsophagusUnited States, India, Czechia, Poland
-
VicalCompletedHead and Neck Cancer | Head and Neck Neoplasms | Carcinoma of the Head and Neck | Squamous Cell Carcinoma of the Oral Cavity or OropharynxUnited States
-
National Cancer Institute, NaplesRecruitingSquamous Cell Carcinoma of the Head and Neck | Squamous Cell Carcinoma of the AnusItaly
-
Swami Rama Cancer Hospital and Research InstituteUnknownLung Cancer | Squamous Cell Carcinoma of the Lung | Locally Advanced and Metastatic Squamous Cell Carcinoma of the LungIndia
-
Ohio State University Comprehensive Cancer CenterNational Comprehensive Cancer NetworkCompletedStage III Squamous Cell Carcinoma of the Oropharynx | Stage IV Squamous Cell Carcinoma of the OropharynxUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMetastatic Squamous Cell Carcinoma of the Hypopharynx | Metastatic Squamous Cell Carcinoma of the Larynx | Metastatic Squamous Cell Carcinoma of the Oral Cavity | Metastatic Squamous Cell Carcinoma of the Oropharynx | Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous... and other conditionsUnited States
-
University of PittsburghNational Cancer Institute (NCI)TerminatedSquamous Cell Carcinoma of the Head and Neck | Squamous Cell Carcinoma, Head And Neck | Carcinoma, Squamous Cell of Head and NeckUnited States
-
Brooklyn ImmunoTherapeutics, LLCCompletedSquamous Cell Carcinoma of the Oral CavityUnited States, Brazil, United Kingdom, Canada
-
Innate PharmaTerminatedSquamous Cell Carcinoma of the Oral CavityGermany, Spain
-
Danish Head and Neck Cancer GroupCompletedCancer of the Head and NeckDenmark
-
AstraZenecaPRA Health SciencesCompletedRecurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and NeckUnited States, Belgium, Canada, France, Spain, Korea, Republic of, Hungary, Malaysia, United Kingdom, Taiwan, Germany, Georgia, Israel, Czechia
-
Cliniques universitaires Saint-Luc- Université...RecruitingSquamous Cell Carcinoma of the Head and NeckBelgium
-
Medical University InnsbruckTerminatedHead and Neck NeoplasmsAustria
-
University of Colorado, DenverCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Acerta Pharma BVMerck Sharp & Dohme LLCCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Grupo de Investigación Clínica en Oncología RadioterapiaCompletedSquamous Cell Carcinoma of the Head and NeckSpain
-
University of ChicagoWithdrawnSquamous Cell Carcinoma of the Head and NeckUnited States
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Brigham and Women's HospitalCompletedC-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and NeckHead and Neck NeoplasmsUnited States
-
Roswell Park Cancer InstituteCompletedRecurrent Thyroid Cancer | Stage II Follicular Thyroid Cancer | Stage II Papillary Thyroid Cancer | Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the... and other conditionsUnited States
-
Institute of Cancer Research, United KingdomNational Cancer Institute (NCI); ECOG-ACRIN Cancer Research GroupRecruitingSquamous Cell Carcinoma of the Penis, Usual TypeUnited States, United Kingdom
-
Vaccinex Inc.Merck Sharp & Dohme LLCRecruitingRecurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)United States
-
AstraZenecaCompletedRecurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHNUnited States, France, Italy, Spain, Belgium, Czechia, Romania, Taiwan, Korea, Republic of, Brazil, Hungary, Japan, Russian Federation, Australia, Germany, Israel, Serbia, Bulgaria, Ukraine, Argentina, Poland, Chile, Croatia, Georgia
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Sanofi; Beth Israel Deaconess Medical Center; Brigham...CompletedSquamous Cell Carcinoma | Carcinoma of Head and/or NeckUnited States
-
University of Colorado, DenverAstraZenecaActive, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States
-
Groupe Oncologie Radiotherapie Tete et CouCompletedSquamous Cell Carcinoma of the Head and NeckFrance
-
CellSight Technologies, Inc.Stanford UniversityCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Assiut UniversityCompletedSquamous Cell Carcinoma of the Head and NeckEgypt
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLC; Institute of Cancer Research, United KingdomTerminatedSquamous Cell Carcinoma of the Head and Neck | Squamous Cell CarcinomaUnited Kingdom
-
PfizerTerminatedSquamous Cell Carcinoma of the Head and NeckUnited States, Spain, China, Taiwan, France, Australia, Hungary, Korea, Republic of, Germany, Japan, Switzerland, Ireland, Israel, United Kingdom, Italy, Poland, Belgium, Canada, Greece, Portugal, Austria, Russian Federation
-
Sanford HealthCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
University of Maryland, BaltimoreNational Institute of Dental and Craniofacial Research (NIDCR)CompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Washington University School of MedicineNovartis PharmaceuticalsCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
HiberCell, Inc.Merck Sharp & Dohme LLCTerminatedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Comprehensive Cancer Network; Vanderbilt-Ingram Cancer CenterTerminatedSquamous Cell Carcinoma of the Head and NeckUnited States
-
SanofiCompletedHead and Neck NeoplasmsChina
-
University Health Network, TorontoCompletedSquamous Cell Carcinoma of the Head and NeckCanada
-
Akamis BioRecruitingSquamous Cell Carcinoma of the Head and NeckUnited Kingdom
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany; GORTEC (Head and Neck Oncology and Radiotherapy...Active, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States, Spain, Korea, Republic of, Taiwan, China, Argentina, France, Japan, Israel, United Kingdom, Belgium, Germany, Portugal, Greece, Italy, Georgia, Australia, Czechia, Brazil, Canada, Austria, Russian Federation, Switzerland and more